MARCKSL1 and esophageal squamous cell carcinoma: A previous systematic and integrative ‘omics’ strategy identified that MARCKSL1 was upregulated in ESCC tissues and that MARCKSL1 augments ESCC cell mobility in vitro,15 but it remains unclear whether MARCKSL1 expression is notably associated with the clinicopathological characteristics of patients with ESCC.